Up-Regulation of TRIM32 Associated With the Poor Prognosis of Acute Myeloid Leukemia by Integrated Bioinformatics Analysis With External Validation

BACKGROUND: Acute myeloid leukemia (AML) is a malignant and molecularly heterogeneous disease. It is essential to clarify the molecular mechanisms of AML and develop targeted treatment strategies to improve patient prognosis. METHODS: AML mRNA expression data and survival status were extracted from...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaoyan, Qi, Jiaqian, Yang, Jingyi, Pan, Tingting, Han, Haohao, Yang, Meng, Han, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213666/
https://www.ncbi.nlm.nih.gov/pubmed/35756612
http://dx.doi.org/10.3389/fonc.2022.848395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213666/
https://www.ncbi.nlm.nih.gov/pubmed/35756612
http://dx.doi.org/10.3389/fonc.2022.848395

Ejemplares similares